Experimental Pill Nearly Doubles Survival in Pancreatic Cancer
A late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
A late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
A senior U.S. defense official is pushing allies to back a quiet Taiwan stance, a move that could redefine regional s...
Wix announces a 20% workforce reduction tied to AI and currency headwinds, as an MIT professor contends the move mirr...
Peter Thiel's AI warning collides with rising demand for storytellers, prompting a reassessment of career paths and p...
A former Workday executive argues that attitude, authenticity, and relationships—not titles—drive success in an AI er...
The disputed billion claim became a flashpoint as the AGA ties prediction markets to tax losses, drawing sharp replie...
A sweeping proposal from former President Donald Trump and ex-Fed official Kevin Warsh would dramatically increase So...
Ford posted solid Q1 results with rising revenue and a booming software business, while GM delivered a robust earning...
In 2026, social security’s special minimum is fading for new retirees. Fewer than 30,000 people still qualify, with m...
In a volatile crypto landscape, traders ask whether a $500 XRP bet made in 2026 could vault to five figures by 2030. ...
A government-backed move accelerates commercialization of quantum tech, and three ETFs are steering investors through...
A new defense AI initiative is rattling markets and family budgets as lawmakers weigh safeguards. A senior official w...